We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$592M
AUM Growth
+$78.5M
Cap. Flow
+$48.3M
Cap. Flow %
8.16%
Top 10 Hldgs %
62.58%
Holding
88
New
16
Increased
4
Reduced
1
Closed
7
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
FNCH icon
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$13.8M
2
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.66M
3
FLNA icon
Filana Therapeutics
FLNA
+$8.48M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$5.53M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$4.6M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$3.9M
2
IDN icon
Intellicheck
IDN
+$2.99M
3
EOSEW icon
Eos Energy Enterprises Warrant
EOSEW
+$2.08M
4
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.53M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 25.7%
2 Miscellaneous 14.31%
3 Industrials 13.57%
4 Consumer Discretionary 12.6%
5 Materials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$76M 12.83%
475,000
– –
2019 Q4
5 quarters
LIN icon
2
Linde
LIN
$228B
$54M 9.11%
192,627
– –
2019 Q4
5 quarters
DRRX icon
3
DELISTED
DURECT Corp
DRRX
$52.3M 8.83%
2,641,466
– –
2019 Q4
5 quarters
BC icon
4
Brunswick
BC
$4.22B
$47.7M 8.05%
500,000
– –
2020 Q1
4 quarters
IVAC icon
5
DELISTED
Intevac Inc
IVAC
$35.4M 5.97%
4,949,355
– –
2019 Q4
5 quarters
INVE icon
6
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$25.2M 4.25%
2,196,389
– –
2019 Q4
5 quarters
OPTU icon
7
Optimum Communications Inc
OPTU
$362M
$22.9M 3.86%
703,600
+100,000
+17% +$3.48M
2020 Q1
4 quarters
FLNA icon
8
Filana Therapeutics
FLNA
$35.7M
$22.5M 3.79%
500,000
+215,686
+76% +$8.48M
2019 Q4
5 quarters
LIQT icon
9
LiqTech
LIQT
$12.7M
$17.5M 2.95%
269,806
– –
2020 Q1
4 quarters
IDN icon
10
Intellicheck
IDN
$45M
$17.4M 2.93%
2,073,583
-255,095
-11% -$2.99M
2019 Q4
5 quarters
THO icon
11
Thor Industries
THO
$3.58B
$14.8M 2.5%
109,753
– –
2020 Q1
4 quarters
SPGI icon
12
S&P Global
SPGI
$125B
$14.1M 2.38%
40,000
– –
2019 Q4
5 quarters
CDXS icon
13
Codexis
CDXS
$146M
$13.3M 2.24%
579,116
– –
2019 Q4
5 quarters
FNCH icon
14
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$13.1M 2.21%
+27,014
New +$13.8M
2021 Q1
0 quarters
MRNS icon
15
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12.8M 2.17%
829,910
+117,410
+16% +$1.7M
2020 Q1
4 quarters
SHLX
16
DELISTED
Shell Midstream Partners, L.P.
SHLX
$12.2M 2.06%
913,347
– –
2019 Q4
5 quarters
GRA
17
DELISTED
W.R. Grace & Co.
GRA
$12M 2.03%
200,934
– –
2020 Q1
4 quarters
LSXMK icon
18
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$10.4M 1.76%
305,187
– –
2019 Q4
5 quarters
ISLE
19
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$9.69M 1.64%
+1,000,000
New +$9.66M
2021 Q1
0 quarters
RPRX icon
20
Royalty Pharma
RPRX
$26.7B
$8.72M 1.47%
200,000
– –
2020 Q2
3 quarters
FATE icon
21
Fate Therapeutics
FATE
$230M
$8.24M 1.39%
100,000
– –
2020 Q2
3 quarters
NS icon
22
DELISTED
NuStar Energy L.P.
NS
$7.44M 1.26%
435,500
– –
2019 Q4
5 quarters
BX icon
23
Blackstone
BX
$87.2B
$5.96M 1.01%
80,000
– –
2019 Q4
5 quarters
DNTH icon
24
Dianthus Therapeutics
DNTH
$4.11B
$5.14M 0.87%
27,150
– –
2020 Q1
4 quarters
DUOT icon
25
Duos Technologies
DUOT
$174M
$4.95M 0.84%
453,616
– –
2020 Q1
4 quarters
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2021 Portfolio in Review

As of Q1 2021, Bleichroeder LP held 88 positions worth $592M, up 15% from $514M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP deployed $48.3M of net new capital in Q1 2021, opening 16 new positions and adding to 4 existing holdings. Its largest new stake was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Intellicheck, an estimated $2.99M trimmed.

  • Bleichroeder LP's largest Q1 2021 buy was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.
  • Bleichroeder LP added most to Filana Therapeutics in Q1 2021, an estimated $8.48M increase.
  • Bleichroeder LP's biggest Q1 2021 reduction was Intellicheck, cutting an estimated $2.99M.
  • Bleichroeder LP fully exited TG Therapeutics in Q1 2021, selling an estimated $3.9M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $592M portfolio in Q1 2021.
  • Bleichroeder LP opened 16 new positions and closed 7 in Q1 2021.
  • Bleichroeder LP's portfolio value rose 15% quarter-over-quarter to $592M.

Based on Bleichroeder LP's 13F filing for Q1 2021, filed 17 May 2021.